Minoxidil in Singapore: Oral vs Topical, Side Effects, and Where Spironolactone and Dutasteride Fit
Medical Director Dr Sin Yong explains what the evidence shows for topical and oral minoxidil, their side effects, their use in women, and how spironolactone and dutasteride compare, with the choice of medicine made at consultation.
WhatsApp to Enquire →Key facts ↓Minoxidil is a medicine that lengthens the growth phase of scalp hair and is used for pattern hair loss in men and women. In Singapore it is used as a topical solution or foam, and as low-dose tablets prescribed off-label. In a 2024 trial in men, oral minoxidil was not superior to topical overall. Spironolactone and dutasteride act on hormones instead and are prescription-only. See anti-hair-loss medications.
- Women: a Cochrane review of 47 trials (5,290 women) found topical minoxidil roughly doubled the chance of moderate to marked regrowth versus placebo (risk ratio 1.93), with no clear difference between 2% and 5% [2].
- Oral vs topical: in a 24-week randomised trial in 90 men, oral minoxidil 5 mg was not superior to topical 5% overall; extra body or facial hair affected 49% on the oral dose [3].
- Low-dose safety: in 1,404 people on low-dose oral minoxidil, excess hair growth occurred in 15.1%, light-headedness in 1.7% and fluid retention in 1.3%; 1.7% stopped because of side effects [4].
- Dutasteride: in a trial of 917 men, dutasteride 0.5 mg increased hair count more than finasteride 1 mg at 24 weeks, with similar side-effect rates [5].
- Spironolactone: a systematic review of 7 studies (618 people, mostly women) found oral and topical spironolactone helpful, especially combined with minoxidil, and called for better trials [7].
How does minoxidil work for hair loss?
Minoxidil began as a blood pressure tablet; hair growth was noticed as a side effect. On the scalp it lengthens the anagen (growth) phase of the hair cycle and supports follicles that are miniaturising. It does this independently of DHT, the hormone that drives pattern hair loss, which is why it is used in both men and women and why it is often paired with a medicine that acts on the hormonal driver. Pattern hair loss affects up to 80% of white men and 42% of women, and the European evidence-based guideline assessed minoxidil alongside the other available treatments [1].
Three practical points decide whether it helps. First, it works only while it is used: the extra growth it supports is usually lost within months of stopping. Second, extra shedding in the first weeks is common, as resting hairs are pushed out ahead of new growth, and stopping at that point is a frequent reason treatment seems to fail. Third, response is judged at three to six months against standardised photographs, not in the mirror after a fortnight. It cannot revive follicles that have already gone.
Oral vs topical minoxidil: which suits whom?
Topical minoxidil is applied as a solution or foam to a dry scalp. Low-dose oral minoxidil is a small tablet dose, far below the doses once used for blood pressure, prescribed off-label for hair loss. The oral route has become popular because it avoids twice-daily application and scalp irritation, but it reaches the whole body.
The head-to-head evidence is more modest than its popularity. In a double-blind randomised trial, 90 men with pattern hair loss took either oral minoxidil 5 mg daily with a placebo solution, or topical minoxidil 5% twice daily with a placebo tablet, for 24 weeks; 68 completed it. Oral minoxidil was not superior overall. Photographs favoured it at the crown but not the front, and 49% of those on the tablet developed extra body or facial hair [3]. Oral minoxidil is therefore a reasonable option for some people, not an automatic upgrade.
| Topical minoxidil | Low-dose oral minoxidil | |
|---|---|---|
| Form | Solution or foam on a dry scalp | A small tablet dose, prescribed and adjusted by a doctor |
| Evidence | Randomised trials in men and women; Cochrane review in women [2] | Not superior to topical 5% in a 24-week trial in men [3]; large safety cohort [4] |
| Common side effects | Scalp itch or flaking, early shedding, facial hair where it runs | Extra body and facial hair; less often light-headedness, fluid retention, fast heartbeat [4] |
| Checked first | Pregnancy and breastfeeding; an inflamed or broken scalp | Heart disease, low blood pressure, kidney problems, other medicines, pregnancy |
| Status in Singapore | A regulated medicine; ask a doctor or pharmacist before starting | Prescription-only; off-label for hair loss |
What are the side effects of minoxidil?
Topical minoxidil mostly causes local problems. Scalp itch, flaking or redness is often due to the base liquid rather than minoxidil itself, and a foam can suit Singapore’s humidity better. Fine facial hair can appear where solution runs onto the forehead or cheeks, and usually settles once application is tidied up.
Oral minoxidil carries body-wide effects, though at low doses they are uncommon. In a retrospective study of 1,404 people taking low-dose oral minoxidil for at least three months, the commonest side effect was excess hair growth (15.1%). Light-headedness occurred in 1.7%, fluid retention in 1.3%, a fast heartbeat in 0.9% and headache in 0.4%; 1.7% stopped because of side effects, and no life-threatening events were seen. The study had no control group [4].
Seek urgent care for chest pain, fainting or a racing heart, and contact your doctor about marked ankle swelling, a rash or shortness of breath. Minoxidil in either form is avoided in pregnancy and while breastfeeding.
Minoxidil for women: what does the evidence show?
Topical minoxidil has the strongest evidence in women. A Cochrane review of 47 trials with 5,290 participants found that women using minoxidil were about twice as likely as those on placebo to report moderate to marked regrowth (risk ratio 1.93), with an average gain of about 13 hairs per square centimetre in eight studies, rated low-quality evidence. The 2% and 5% strengths did not clearly differ, and finasteride 1 mg was no more effective than placebo in women [2].
Women’s thinning more often has a contributing cause, such as low iron stores, thyroid disease, shedding after childbirth or illness, or polycystic ovary syndrome, so blood tests usually come before any medicine. See female hair loss treatment and postpartum hair loss.
Where do spironolactone, finasteride and dutasteride fit?
These medicines act on the hormonal driver rather than the growth phase. Finasteride blocks one form of the enzyme that converts testosterone to DHT; dutasteride blocks both forms. In a randomised trial of 917 men, dutasteride 0.5 mg increased hair count and hair width more than finasteride 1 mg at 24 weeks, with similar numbers of side effects [5]. A meta-analysis of three trials (576 men) reached the same conclusion and found no significant difference in sexual side effects between the two [6]. In Singapore, as in many countries, dutasteride is registered mainly for an enlarged prostate, so its use for hair loss is off-label.
Spironolactone blocks the effect of androgens and is used in selected women. A systematic review of 7 studies (618 people, 553 of them women) found both oral and topical spironolactone helpful, with better results when combined with minoxidil; oral doses mostly ranged from 80 to 110 mg a day, and the authors asked for higher-quality randomised trials [7]. Spironolactone is not used in pregnancy, because anti-androgens can affect a male foetus, so contraception is discussed first; blood pressure, potassium and period changes are monitored.
| Medicine | How it works | Mainly used in | Key cautions |
|---|---|---|---|
| Minoxidil (topical or oral) | Lengthens the growth phase; not hormonal | Men and women | Shedding early on; oral route has body-wide effects [4] |
| Finasteride | Lowers DHT (one enzyme form) | Men | Sexual side effects in a minority; not for women who may become pregnant |
| Dutasteride | Lowers DHT (both enzyme forms) | Men; off-label for hair | Similar side effects to finasteride [6]; not for women who may become pregnant |
| Spironolactone | Blocks androgen effects | Selected women; off-label for hair | Not in pregnancy; blood pressure, potassium, irregular periods [7] |
How is hair loss medicine chosen at IN Eternity Clinic?
The cause comes first. Dr Sin Yong takes a history, examines the scalp with trichoscopy, takes standardised photographs and requests blood tests such as ferritin and thyroid function where the pattern suggests them. Shedding from low iron, thyroid disease or recent illness is treated first, because it can look like pattern loss but needs different care.
The clinic’s medical layer, set out on its anti-hair-loss medications page, can include topical minoxidil, an oral prescription that lowers scalp DHT, and selected anti-androgens for some women. Whether oral minoxidil, spironolactone, dutasteride or any other medicine suits you is decided by Dr Sin Yong at consultation, after discussing benefits, side effects, pregnancy plans and your other medicines. In-clinic options such as H2LT laser and Regenera Activa can be added if the response is partial, with reviews at about three and six months. Results vary between people. See hair loss treatment in Singapore and male hair loss treatment.
What Dr Sin Yong looks for
- The pattern: temples and crown, a widening parting, or shedding all over.
- Blood pressure, heart history and current medicines before any oral option is discussed.
- Pregnancy plans, contraception and breastfeeding in women; family plans in men.
- Iron, thyroid and other blood results where shedding or a female pattern suggests them.
- What has been tried, for how long, and how the scalp tolerated it.
General clinical observations used at consultation; they describe what is checked, not any individual result.
Frequently asked questions
Can I get oral minoxidil in Singapore?
Oral minoxidil is prescription-only in Singapore, and its use for hair loss is off-label, so it is prescribed only after a doctor has examined the scalp, confirmed the cause and checked blood pressure, heart history and other medicines. Whether it suits you is decided at consultation; for many people topical minoxidil is the starting point.
What are the side effects of minoxidil?
Topical minoxidil can cause scalp itch or flaking, early shedding in the first weeks, and fine facial hair where it runs. Low-dose oral minoxidil most often causes extra body or facial hair; light-headedness, fluid retention and a fast heartbeat are less common. Chest pain, fainting or marked ankle swelling need prompt medical attention.
Is oral minoxidil better than topical minoxidil?
Not clearly. In a 24-week randomised trial in men, oral minoxidil 5 mg was not superior overall to topical 5% twice daily, though photographs favoured it at the crown. Oral minoxidil can suit people who cannot tolerate or keep up with a topical, but it has more body-wide side effects and needs medical review.
Does minoxidil work for women?
Yes, for female pattern hair loss. A Cochrane review found women using topical minoxidil were about twice as likely as those on placebo to report moderate to marked regrowth, with no clear difference between 2% and 5%. Women’s hair loss more often has a contributing cause such as low iron or thyroid disease, so this is checked first.
Why is my hair shedding after starting minoxidil?
Extra shedding in the first weeks is common: resting hairs are pushed out as new growth starts. It usually settles within a couple of months, and stopping at this point is a common reason treatment appears to fail. Heavy shedding, or shedding that lasts longer, should be reviewed by your doctor.
Can I get spironolactone in Singapore for hair loss?
Spironolactone is prescription-only in Singapore, and its use for hair loss is off-label. It is considered only for selected women with pattern or hormonal hair loss, after blood tests, and is not used in pregnancy or without reliable contraception in women who could conceive. Suitability is decided by the doctor at consultation.
Is dutasteride available in Singapore for hair loss?
Dutasteride is prescription-only in Singapore and registered mainly for an enlarged prostate, so its use for hair loss is off-label. In trials in men it increased hair count more than finasteride over 24 weeks, with similar side-effect rates. Whether it is appropriate for you is a decision for the doctor after assessment.
What happens if I stop minoxidil?
The extra growth it supports is usually lost within a few months of stopping, and pattern loss continues from where it would otherwise have been. That is why minoxidil is treated as a long-term medicine, and why it is worth deciding at the start whether you are prepared to continue it.
Book an assessment
IN Eternity Clinic, 9 Scotts Road, #12-01 Pacific Plaza, Singapore 228210. By appointment with Medical Director Dr Sin Yong. Monday to Saturday, 11am to 8pm. WhatsApp or call +65 8815 3008. At IN Eternity Clinic a consultation fee applies, and it is waived if you go ahead with any medical treatment; the fee is S$120.
International KOL — CLASSYS · HIRONIC · DEKA · ALMA · FOTONA · LUTRONIC
References
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol 2018;32(1):11-22. doi:10.1111/jdv.14624
- van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev 2016;(5):CD007628. doi:10.1002/14651858.CD007628.pub4
- Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol 2024;160(6):600-605. doi:10.1001/jamadermatol.2024.0284
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol 2021;84(6):1644-1651. doi:10.1016/j.jaad.2021.02.054
- Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol 2014;70(3):489-498.e3. doi:10.1016/j.jaad.2013.10.049
- Zhou Z, Song S, Gao Z, et al. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clin Interv Aging 2019;14:399-406. doi:10.2147/CIA.S192435
- Wang C, Du Y, Bi L, et al. The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review. Clin Cosmet Investig Dermatol 2023;16:603-612. doi:10.2147/CCID.S398950
These sources describe mechanisms and general evidence. They are not a promise of any individual result; suitability is decided at an in-person assessment.